Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid for reducing perioperative hidden blood loss in intertrochanteric fracture treated with PFNA
ChiCTR2000033135Phase 4Completed
- Sponsor
- Second Affiliated Hospital of Kunming Medical University
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tranexamic acid in intertrochanteric fracture (3 arms), sponsored by Second Affiliated Hospital of Kunming Medical University. Primary endpoint: Blood routine. Started Jul 2019; status: completed.
02
Drugs
tranexamic acid
03
Conditions
intertrochanteric fracture
Beyond the preview
Go deeper on ChiCTR2000033135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000033135.